Beneficial Effects of Octreotide in a Patient with a Metastatic Paraganglioma

European Journal of Cancer

Volumn 32, Issue 4, 1996, Pages 737-

  Tenenbaum, F ^a   Schlumberger, M ^a   Lumbroso, J ^a   Parmentier, C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; OCTREOTIDE; PENTETREOTIDE;

ADULT; CASE REPORT; HUMAN; LETTER; MALE; METASTASIS; PARAGANGLIOMA; PRIORITY JOURNAL; SCINTIGRAPHY;

ADRENAL GLAND NEOPLASMS; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BONE NEOPLASMS; HUMANS; MALE; OCTREOTIDE; PARAGANGLIOMA; TREATMENT OUTCOME;

EID: 0029933926     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00617-6     Document Type: Letter

References (4)

1. Kwekkeboom DJ, van Urk H, Pauw BKH, et al. Octreotide scintigraphy for the detection of paragangliomas. J Nucl Med 1993, 34, 873-878.
2. Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Parmentier C. Comparison of radiolabeled octreotide and MIBG scintigraphy in malignant pheochromocytoma. J Nucl Med 1995, 36, 1-6.
3. Plouin PF, Zacharieva S, Bertherat J, Billaud E, Epelbaum J. Are pheochromocytoma somatostatin binding sites functional? Am J Hypertens 1993, 61, 60A.
4. Harris AG, Kokoris SP. Therapeutic applications of somatostatin and its analogue octreotide. Eur J Med 1993, 2, 97-105.